Lyra Therapeutics Inc. (LYRA)

AI Score

Unlock

0.10

0.00 (0.91%)

At close: Apr 25, 2025, 3:59 PM

0.10

3.35%

After-hours: Apr 25, 2025, 05:45 PM EDT

Lyra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	40.58M	23.8M	31.91M	15.8M	22.35M	24.85M	54.36M	22.02M	32.55M	109.56M	120.67M	33.76M	45.75M	58.13M	69.05M	66.11M	74.59M	81.56M	86.6M	35.25M	9.81M	-23.89M
Short-Term Investments	n/a	27.83M	35.59M	71.32M	80.4M	77.7M	61.79M	60.69M	65.34M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	47.78M
Long-Term Investments	n/a	n/a	n/a	1.99M	1.39M	1.39M	1.09M	n/a	1.39M	n/a	1.09M	329K	329K	329K	329K	329K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.99M	1.99M	1.99M	683K	1.11M	7.46M	4.35M	5.24M	3.28M	2.87M	1.7M	1.08M	762K	245K	243K	n/a	447K	329K	329K	1.98M	1.43M	-23.89M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.45M	2.82M	1.94M	2.33M	2.07M	2.37M	2.1M	2.09M	2.94M	329K	329K	n/a	2.17M	2.75M	1.03M	n/a	1.32M	2M	2.71M	293K	n/a	n/a
Total Current Assets	43.02M	54.44M	69.44M	89.44M	104.82M	104.92M	118.25M	84.8M	100.83M	112.23M	122.38M	40.55M	47.92M	60.89M	70.07M	67.35M	75.92M	83.56M	89.31M	35.54M	10.12M	23.89M
Property-Plant & Equipment	21.33M	22.32M	23.16M	49.41M	35.28M	6.8M	1.98M	3.83M	4.47M	4.36M	4.87M	5.38M	5.86M	6.3M	5.69M	5.24M	4.47M	3.45M	3.08M	3.25M	3.42M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	23.32M	24.31M	25.15M	52.08M	37.78M	15.65M	7.42M	9.07M	9.14M	7.23M	7.65M	6.79M	6.95M	6.88M	6.26M	5.57M	4.91M	3.77M	3.41M	5.23M	4.84M	-23.89M
Total Assets	66.35M	78.76M	94.58M	141.53M	142.6M	120.58M	125.67M	93.87M	109.97M	119.46M	130.03M	47.34M	54.87M	67.76M	76.33M	72.92M	80.83M	87.33M	92.72M	40.77M	14.96M	n/a
Account Payables	1.18M	2.29M	4.97M	2.84M	3.13M	5.05M	4.19M	3.95M	2.62M	2.9M	1.67M	2.41M	3.13M	2.91M	1.9M	1.17M	922K	530K	1.15M	1.36M	1.07M	n/a
Deferred Revenue	398K	607K	814K	1.32M	1.66M	1.73M	1.5M	1.51M	1.27M	2.73M	1.81M	10.06M	9.79M	9.84M	12M	1.93M	2.83M	3.1M	1.74M	2.73M	3.13M	n/a
Short-Term Debt	n/a	n/a	4.27M	n/a	5.43M	1.4M	1.69M	n/a	1.96M	654K	926K	1.1M	n/a	1.05M	n/a	n/a	n/a	964K	943K	919K	n/a	n/a
Other Current Liabilities	4.82M	4.86M	-1.14M	n/a	-730K	-1.4M	-1.69M	n/a	6.05M	3.58M	2.45M	1.61M	1.83M	672K	1.17M	781K	149K	657K	-221K	943K	110K	n/a
Total Current Liabilities	12.63M	14.95M	19.28M	18.72M	19.6M	19.23M	14.11M	14.15M	14.47M	13.61M	9.87M	17.8M	18.25M	17.77M	5.9M	4.17M	4.88M	4.71M	3.94M	5.16M	5.21M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	160.2M	n/a	n/a
Total Long-Term Liabilities	42.12M	43.18M	44.33M	45.3M	33.58M	17.1M	12.99M	13.62M	14.74M	12.64M	9.13M	1.39M	2.31M	2.8M	12.93M	1.2M	1.45M	1.71M	1.96M	162.39M	2.43M	n/a
Total Liabilities	54.75M	58.14M	63.6M	64.02M	53.18M	36.34M	27.1M	27.78M	29.21M	26.24M	19M	19.19M	20.55M	20.57M	18.83M	5.37M	6.34M	6.42M	5.9M	167.55M	7.63M	n/a
Total Debt	34.38M	35.32M	36.75M	37.86M	26.88M	6.29M	1.69M	2.09M	2.22M	657K	929K	1.2M	1.45M	1.71M	1.96M	2.2M	2.44M	2.67M	2.9M	3.11M	3.33M	n/a
Common Stock	65K	65K	65K	61K	57K	50K	50K	32K	32K	32K	32K	13K	13K	13K	13K	13K	13K	13K	13K	n/a	6K	n/a
Retained Earnings	-404.79M	-393.81M	-381.94M	-333.81M	-311.36M	-296.2M	-280.55M	-264.93M	-248.68M	-234.44M	-214.89M	-200.41M	-193.4M	-179.78M	-168.72M	-157.69M	-149.88M	-142.86M	-136.53M	-131.99M	-127.76M	n/a
Comprehensive Income	n/a	20K	-4K	25K	33K	-7K	-27K	-12K	10K	n/a	-0.00	n/a	n/a	n/a	-0.00	0.00	-0.00	-87.33M	-2.85M	-2.84M	-2.83M	-107.07M
Shareholders Equity	11.59M	20.62M	30.98M	77.5M	89.42M	84.24M	98.58M	66.09M	80.75M	93.22M	111.03M	28.16M	34.32M	47.19M	57.5M	67.55M	74.49M	80.91M	86.82M	-126.78M	7.33M	23.28M
Total Investments	n/a	27.83M	35.59M	73.31M	81.79M	77.7M	61.79M	60.69M	65.34M	n/a	1.09M	329K	329K	329K	329K	329K	n/a	n/a	n/a	n/a	n/a	47.78M